Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
×

Get our best content in your email.

You are already a member! Please enter your password to sign in.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Resverlogix Corp T.RVX

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  RVXCF

Resverlogix Corp is a clinical stage cardiovascular company. It is engaged in developing RVX-208, a molecule selective inhibit BET domain inhibitor for the treatment of patients with cardiovascular, diabetes mellitus, Alzheimer's & chronic kidney disease.
Price: $1.82 | Change: $0.00 | %Change: 0.00%
Volume: 5,266 | Day High/Low: 1.83/1.77 | 52 Week High/Low: 3.13/0.405
View modes: 
3 stars

RE:gv...MACE vs. QoL vs. Lipitor-Crestor or 208...

prince..those are all good questions. I simply don't know how RVX-208 will be prescribed over statins. Will it be prescribed in addition to a statin or instead of? For example, I was not on a statin...read more
0 stars

gv...MACE vs. QoL vs. Lipitor-Crestor or 208...

..so thinking forward, if 208 proves to possess a 27.5% RRR MACE vs. others, in real life would that be meaningful to your doctor or is it a whole range of QoL factors that come into play, knowing i...read more
0 stars

250 Events

@ 27.5% RRR 208 105 - SoC 145 Events @ 75% RRR 208 50 - SoC 200 Events... ...IMO those are two very different paradigms, in the 27.5% plan i see a very good difference but IMO QoL of non-MACE...read more
1 star

RE:RE:RE:RE:RE:RE:RE:GV, a question of your experience with Lipitor???

I've had The identical experience...Crestor took ALL the muscle pains away..:)  rate and reply
0 stars

RE:RE:RE:RE:RE:RE:GV, a question of your experience with Lipitor???

Just a short comment on Lipitor versus Crestor. In my personal experience after taking Lipitor for a number of years my doctor switched me to Crestor a number of Years ago. This was prior to being...read more
1 star

RE:RE:RE:RE:RE:GV, a question of your experience with Lipitor???

toinv...please do not misunderstand what is being said. There is no suggestion that that anyone would stop taking statins of any brand during the BonM trials for any reason.  What I am saying is that...read more
0 stars

RE:RE:RE:RE:GV, a question of your experience with Lipitor???

Hi GV. I wonder why, in the BETonMACE trial phase lll, anyone would stop taking Crestor? As I understand it the patients will remain on their standard of care treatment (Crestor or Liptitor) and on a...read more
1 star

RE:RE:RE:RE:RE:RE:RE:GV, a question of your experience with Lipitor???

prince..that explains it.  thx. :)  rate and reply
1 star

RE:RE:RE:RE:RE:RE:GV, a question of your experience with Lipitor???

gv, you don't want researchers biasing the trial the safety board will know but no one active in the trial should know...at specific point(s) data will be unblinded but mid-trial only for safety...read more
1 star

RE:RE:RE:RE:RE:GV, a question of your experience with Lipitor???

prince ...I know the patients would not know but if the researchers don't know who is taking what how can they conduct the study to see what's what? I am not disputing what you are saying because I...read more
1 star

RE:RE:RE:RE:GV, a question of your experience with Lipitor???

gv, you is wrong, double blind means neither patient nor trial staff know who gets what...only way to tell (like cheating) is by knowing if there are different treatment effects (like x generates a...read more
1 star

RE:RE:RE:GV, a question of your experience with Lipitor???

prince ...yes BonM is double blinded. But  the clinic would certainly know the 4 groups. If I should decide to stop taking Crestor overnight I would not feel any different, however I would need to...read more
1 star

RE:RE:GV, a question of your experience with Lipitor???

gv, isn't this a double blinded trial (ie no body knows who gets assigned exactly to what of the four arms)???? and how long would you before you started to feel "bad" if you stopped taking Crestor???  rate and reply
1 star

RE:GV, a question of your experience with Lipitor???

prince...I am on Crestor. I did ask my cardiologist why one and not the other. I never did get a satisfactory answer. But I doubt patients on BonM trials would be told to change from one to the other...read more
1 star

GV, a question of your experience with Lipitor???

and related to BoM...i assume you are on Lipitor as for you it was deemed to likely be more effective than Crestor..so say you are "high risk" and for this trial need to "clean up" (attain some...read more
5 stars

RE:RE:RE:RE:We need some confidence and action!

Correction: Hypothetically, if they are able to enroll 1200 patients by the start of EACH of the 3 quarters Q1 2016, Q2 2016 and Q3 2016, (reaching 3600 patients by start of Q3 2016), then by the end...read more
5 stars

RE:RE:RE:We need some confidence and action!

G1945V, What I mean is that: 1) If FDA approval already exists by the time of BETonMACE enrollment if Fall 2015, then likely USA patients be able to be enrolled in BETonMACE right away. Alternatively...read more
1 star

RE:RE:RE:We need some confidence and action!

gv,  enrollment of US patients is IMO not an issue...in fact it is likely the FDA is OK with the now revised (again a major revision which speaks to design failure) trial design but as best i know the...read more
1 star

RE:RE:We need some confidence and action!

Bear, are you saying that enrollment will also include patients in the USA (in fall of 2105) for BonM even without FDA approval? G1945V  rate and reply
5 stars

RE:We need some confidence and action!

Also Ron, if you want to take comfort in the misfortune of others.....take a looks at how Esperion (ESPR) and their ETC-1002 LDL-lowering drug have taken a hit over the past 3 months or so based upon...read more